Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9262 |
High Similarity |
NPD3027 |
Phase 3 |
0.9083 |
High Similarity |
NPD2982 |
Phase 2 |
0.9083 |
High Similarity |
NPD2983 |
Phase 2 |
0.9 |
High Similarity |
NPD2981 |
Phase 2 |
0.879 |
High Similarity |
NPD3018 |
Phase 2 |
0.8571 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8492 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8475 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.8468 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.8462 |
Intermediate Similarity |
NPD228 |
Approved |
0.845 |
Intermediate Similarity |
NPD1613 |
Approved |
0.845 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.823 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.8197 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.814 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.813 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.8116 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.8074 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.8016 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.8015 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.792 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7833 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7833 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7803 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7778 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7778 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7761 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7752 |
Intermediate Similarity |
NPD4749 |
Approved |
0.774 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7734 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7714 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.7714 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7698 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7671 |
Intermediate Similarity |
NPD1934 |
Approved |
0.766 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7635 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7615 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7612 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7597 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7586 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7576 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7551 |
Intermediate Similarity |
NPD37 |
Approved |
0.7542 |
Intermediate Similarity |
NPD846 |
Approved |
0.7542 |
Intermediate Similarity |
NPD940 |
Approved |
0.7519 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7517 |
Intermediate Similarity |
NPD1653 |
Approved |
0.75 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7483 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7481 |
Intermediate Similarity |
NPD3145 |
Approved |
0.7481 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7481 |
Intermediate Similarity |
NPD3144 |
Approved |
0.7478 |
Intermediate Similarity |
NPD2933 |
Approved |
0.7478 |
Intermediate Similarity |
NPD9296 |
Approved |
0.7478 |
Intermediate Similarity |
NPD2934 |
Approved |
0.7464 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7459 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7448 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7447 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7447 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7438 |
Intermediate Similarity |
NPD968 |
Approved |
0.7431 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7426 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7424 |
Intermediate Similarity |
NPD2922 |
Phase 1 |
0.7417 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7414 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7414 |
Intermediate Similarity |
NPD2859 |
Approved |
0.74 |
Intermediate Similarity |
NPD4966 |
Approved |
0.74 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.74 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7398 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7388 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7386 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7379 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7373 |
Intermediate Similarity |
NPD3020 |
Approved |
0.7372 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7372 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7361 |
Intermediate Similarity |
NPD5297 |
Approved |
0.736 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7353 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7353 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7353 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7351 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7328 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7323 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7323 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7319 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7313 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7305 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.729 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.729 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7286 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7285 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7266 |
Intermediate Similarity |
NPD1607 |
Approved |
0.726 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7258 |
Intermediate Similarity |
NPD5451 |
Approved |
0.725 |
Intermediate Similarity |
NPD291 |
Approved |
0.7244 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7237 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7236 |
Intermediate Similarity |
NPD290 |
Approved |
0.7236 |
Intermediate Similarity |
NPD1358 |
Approved |
0.723 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.723 |
Intermediate Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7203 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7192 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7161 |
Intermediate Similarity |
NPD4606 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7123 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7122 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7121 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7115 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7113 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7113 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7113 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7107 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7107 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7103 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7103 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7092 |
Intermediate Similarity |
NPD6896 |
Approved |
0.7092 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7092 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7092 |
Intermediate Similarity |
NPD6895 |
Approved |
0.7092 |
Intermediate Similarity |
NPD4538 |
Approved |
0.709 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.709 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7089 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7089 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7087 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7083 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7077 |
Intermediate Similarity |
NPD1408 |
Clinical (unspecified phase) |
0.7075 |
Intermediate Similarity |
NPD1424 |
Approved |
0.7067 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7063 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.705 |
Intermediate Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.7045 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7045 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7045 |
Intermediate Similarity |
NPD2668 |
Approved |
0.7045 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7045 |
Intermediate Similarity |
NPD2667 |
Approved |
0.7044 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7039 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7039 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7037 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7034 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7034 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7034 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7034 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7034 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7023 |
Intermediate Similarity |
NPD7534 |
Approved |
0.7023 |
Intermediate Similarity |
NPD7533 |
Approved |
0.702 |
Intermediate Similarity |
NPD5089 |
Approved |
0.702 |
Intermediate Similarity |
NPD5090 |
Approved |
0.7016 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7015 |
Intermediate Similarity |
NPD2233 |
Approved |
0.7015 |
Intermediate Similarity |
NPD2232 |
Approved |
0.7015 |
Intermediate Similarity |
NPD2230 |
Approved |
0.7015 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7014 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7007 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7 |
Intermediate Similarity |
NPD943 |
Approved |
0.6993 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.6991 |
Remote Similarity |
NPD111 |
Approved |
0.6975 |
Remote Similarity |
NPD7808 |
Phase 3 |
0.697 |
Remote Similarity |
NPD1651 |
Approved |
0.6966 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6966 |
Remote Similarity |
NPD6674 |
Discontinued |
0.6963 |
Remote Similarity |
NPD1669 |
Approved |
0.6957 |
Remote Similarity |
NPD3537 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD9094 |
Approved |
0.6957 |
Remote Similarity |
NPD6797 |
Phase 2 |
0.6953 |
Remote Similarity |
NPD821 |
Approved |
0.695 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.695 |
Remote Similarity |
NPD447 |
Suspended |
0.695 |
Remote Similarity |
NPD3657 |
Discovery |
0.695 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.695 |
Remote Similarity |
NPD4340 |
Discontinued |
0.6948 |
Remote Similarity |
NPD6788 |
Approved |
0.6944 |
Remote Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.6934 |
Remote Similarity |
NPD4624 |
Approved |
0.6933 |
Remote Similarity |
NPD3686 |
Approved |
0.6933 |
Remote Similarity |
NPD3687 |
Approved |
0.6929 |
Remote Similarity |
NPD9280 |
Clinical (unspecified phase) |
0.6929
|
Remote Similarity |
NPD6233 |
Phase 2 |